A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer

PURPOSE: To assess the therapeutic value of biomarker-guided chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). METHODS: Eighty-five NSCLC patients at stage IIIb or IV were divided into two groups based on the feasibility of biomarker analysis. Group A included patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiang, Zhu, Xiaoli, Zhang, Li, Sun, Siqing, Huang, Jing, Lin, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175041/
https://www.ncbi.nlm.nih.gov/pubmed/25119181
http://dx.doi.org/10.1007/s00280-014-2513-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175041/
https://www.ncbi.nlm.nih.gov/pubmed/25119181
http://dx.doi.org/10.1007/s00280-014-2513-x

Ejemplares similares